Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A

Juan Carlos Ruiz-Rodríguez1,2, Luis Chiscano-Camón1,2, Clara Palmada1,2

  • 1Intensive Care Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Insights

Multisystem Inflammatory Syndrome in Children (MIS-C) linked to COVID-19 involves severe inflammation. A hemadsorption device was used to manage the cytokine storm in affected children.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition linked to COVID-19.
  • MIS-C presents with hypercytokinemia, causing excessive inflammation.
  • Cytokine storm is a critical aspect of severe MIS-C.

Observation:

  • The study describes the application of a hemadsorption device.
  • This device was utilized as a component of supportive care.
  • The intervention targeted the cytokine storm in pediatric patients.

Findings:

  • Hemadsorption devices can be integrated into the management of MIS-C.
  • This approach addresses the hyperinflammatory state characteristic of the syndrome.
  • The use of hemadsorption offers a potential strategy for supportive treatment.

Implications:

  • This highlights a novel therapeutic option for severe MIS-C cases.
  • Further research may explore the efficacy and outcomes of hemadsorption in pediatric critical care.
  • Managing cytokine storm with devices like hemadsorbers could improve patient prognoses.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
43
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
49
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
69